Expression of CTGF is known to be induced by RhoA signaling and it is over-expressed in many types of cancers, including head and neck squamous cell carcinoma [36], pancreatic cancer [37], gastric cancer [38], and in pre-B acute lymphoblastic leukaemia [39]. This evidence concerns the gene CCN2 and gastric cancer.